ADPT

Adaptive Biotechnologies (ADPT)

About Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Details

Daily high

$16.06

Daily low

$15.50

Price at open

$15.66

52 Week High

$20.76

52 Week Low

$5.80

Market cap

2.4B

Dividend yield

0.00%

Volume

89,513

Avg. volume

3.2M

P/E ratio

-29.16

Adaptive Biotechnologies News